Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 9 matching records.
9 results — page 1 of 1
- Level BRandomized Controlled TrialPubMed
Evaluation of Multiple Intravenous Infusions of Autologous Adipose-Derived Mesenchymal Stem Cells in Parkinson's Disease: A Randomized, Double-Blind Clinical Trial.
Randomized Controlled Trial with a reported sample of 24 on Neuroinflammation, published in Parkinsons Dis (2026) — summary generated from the PubMed abstract.
- 2026
- n = 24
Parkinsons Dis - Level CProspective StudyPubMed
Safety and Potential Effect of Intrauterine Infusion of Autologous Adipose Tissue-Derived Regenerative Cells in Patients With Implantation Failure: A Pilot Study.
Prospective Study on Systemic / IV, published in Cureus (2024) — summary generated from the PubMed abstract.
- 2024
Cureus3 citations - Level CCase Report / SeriesPubMed
Functional recovery of a 41-year-old quadriplegic spinal cord injury patient following multiple intravenous infusions of autologous adipose-derived mesenchymal stem cells: a case report.
Case Report / Series on Spinal Cord Injury, published in Front Transplant (2023) — summary generated from the PubMed abstract.
- 2023
Front Transplant - Level BClinical TrialPubMed
Intra-arterial renal infusion of autologous mesenchymal stem cells for treatment of chronic kidney disease in cats: Phase I clinical trial.
Clinical Trial on Chronic Kidney Disease, published in J Vet Intern Med (2019) — summary generated from the PubMed abstract.
- 2019
J Vet Intern Med17 citations - Level BClinical TrialPubMed
In a Phase 1a escalating clinical trial, autologous mesenchymal stem cell infusion for renovascular disease increases blood flow and the glomerular filtration rate while reducing inflammatory biomarkers and blood pressur
Clinical Trial with a reported sample of 21 on Systemic / IV, published in Kidney Int (2019) — summary generated from the PubMed abstract.
- 2019
- n = 21
Kidney Int60 citations - Level BClinical TrialPubMed
Systemic Infusion of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Peritoneal Dialysis Patients: Feasibility and Safety.
Clinical Trial on Chronic Kidney Disease, published in Cell J (2018) — summary generated from the PubMed abstract.
- 2018
Cell J22 citations - Level DAnimal StudyPubMed
Effects of autologous adipose-derived stem cell infusion on type 2 diabetic rats.
Animal Study on Systemic / IV, published in Endocr J (2015) — summary generated from the PubMed abstract.
- 2015
Endocr J37 citations - Level CProspective StudyPubMed
Co-infusion of autologous adipose tissue derived insulin-secreting mesenchymal stem cells and bone marrow derived hematopoietic stem cells: viable therapy for type III.C. a diabetes mellitus.
Prospective Study on Systemic / IV, published in Biomed J (2013) — summary generated from the PubMed abstract.
- 2013
Biomed J - Level CProspective StudyPubMed
Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells.
Prospective Study with a reported sample of 10 on Neuroinflammation, Autoimmune Research, published in J Transl Med (2011) — summary generated from the PubMed abstract.
- 2011
- n = 10
J Transl Med124 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406